RBWH15
RBWH15 is a synthetic broad-spectrum antimicrobial peptide. RBWH15 increases the permeability of bacterial outer and inner membranes, disrupts membrane integrity and induces bacterial death. RBWH15 exhibits biofilm eradication activity and can eliminate established bacterial biofilms. RBWH15 shows broad-spectrum antimicrobial activity against Gram-negative and Gram-positive ESKAPE pathogens, including multidrug-resistant strains. RBWH15 can be used in the research of multidrug-resistant bacterial infections.
For research use only. We do not sell to patients.
- Formula: C79H143N19O14
- Molecular Weight:1583.10
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
RBWH15 (0.375-18 μM, >200 μM; 18-24 h) potently inhibits the growth of multiple Gram-positive and Gram-negative ESKAPE pathogens, including methicillin-resistant S. aureus ATCC43300, with MIC values ranging from 1.5 μM to 18 μM, and shows no activity against E. faecalis ATCC19433 at tested concentrations[1].
RBWH15 (2.3-36 μM, 9-144 μM) permeabilizes the outer membranes of S. aureus ATCC25923 and P. aeruginosa PAO1 in a concentration-dependent manner[1].
RBWH15 (2.3-36 μM, 9-144 μM) disrupts the inner membranes of S. aureus ATCC25923 and P. aeruginosa PAO1 in a concentration-dependent manner, leading to increased PI uptake by membrane-compromised bacteria[1].
RBWH15 (2.3-36 μM, 9-144 μM; 90 min, 24 h) eradicates preformed biofilms of S. aureus ATCC25923 and P. aeruginosa PAO1 in a concentration-dependent manner[1].
RBWH15 (2.5-10 μM; 24-48 h) promotes migration of L929 mouse fibroblasts, accelerating in vitro wound closure over 48 h of incubation[1].
RBWH15 (30 min-24 h) exhibits moderate stability in human plasma, with ~35-44% of the peptide remaining intact after 24 h of incubation at 37 °C[1].
RBWH15 (30-60 μM; 1-3 h) is non-hemolytic against murine and human RBCs at concentrations up to 60 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:ESKAPE pathogens
-
Concentration:0.375-200 μM
-
Incubation Time:18-24 h
-
Result:Potently inhibited the growth of various Gram-positive and Gram-negative ESKAPE pathogens-including Staphylococcus aureus ATCC 43300 (MRSA)-with MIC values ranging from 1.5 μM to 18 μM, while showing no activity against Enterococcus faecalis ATCC 19433 at the tested concentrations.
-
Cell Line:L929 mouse fibroblasts
-
Concentration:2.5 μM; 5 μM; 10 μM
-
Incubation Time:24 h; 48 h
-
Result:Promoted the migration of L929 mouse fibroblasts.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:unspecified strain (n=3 per group)[1]
-
Dosage:0.3 mg/kg
-
Administration:i.v.; single dose
-
Result:Showed a non-significant body weight reduction of 2.97% 24 hours post-injection.
Chemical Information
-
Molecular Weight 1583.10
-
Formula C79H143N19O14
-
Sequence
IIKKLLGKLAKFVL-NH2
-
Sequence Shortening
Ile-Ile-Lys-Lys-Leu-Leu-Gly-Lys-Leu-Ala-Lys-Phe-Val-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- RBWH15
- RBWH 15
- RBWH-15
- Bacterial
- S. aureus ATCC25923
- L929 mouse fibroblasts
- A. baumannii AB5075
- HEK293 cells
- P. aeruginosa PAO1
- Gram-negative ESKAPE pathogens
- E. faecalis ATCC19433
- multidrug-resistant bacterial infections
- Gram-positive ESKAPE pathogens
- methicillin-resistant S. aureus ATCC43300
- Inhibitor
- inhibitor
- inhibit